bispecific antibodyimmunotherapymultiple myelomaEffective novel therapies for multiple myeloma (MM) patients who are unresponsive to conventional treatments (triple-class refractory) are an urgent need. Bispecific antibodies (BsAbs) offer a promising new approach to stimulate T cells and...
Innovative treatments give hope to patients with blood cancer Dr. Leslie and Michael speak about CAR T-cell therapies for cancers like LBCL and how eligible patients and caregivers can learn more about these treatments. Read More Multiple Myeloma ...
Go to: ’An Overview of Leukemia cancer - symptoms causes and alternative treatments 2024 Research Pesticides and Herbicides as cancer-causing as smoking Natural Compounds and alternative treatments for leukaemia Iodine and cancer CoQ10 and cancer Why you should change your diet, whatever the oncolog...
This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others Read more October 2, 2024 What’s the difference between a heart attack and cardiac arrest? Read more October 24, 2024 Meet the...
The legend explains that allogeneic stem cell transplantation (Allo-SCT), chemotherapy (ChT), and hypomethylating agents (HMAs) are the possible treatments for MDS. Acute myeloid leukaemia (AML) and red blood cells (RBCs) are also mentioned. It is worth noting that for IPSS-R intermediate-...
Stem cells head to the clinic: treatments for cancer, diabetes and Parkinson’s disease could soon be here More than 100 clinical trials put stem cells for regenerative medicine to the test. It’s a turning point for a field beset with ethical and political controversy. ...
Saad Z. Usmani, MD, MBA, FACP, FASCO, discusses the CEPHEUS trial results and impact on frontline treatment in transplant-ineligible patients with newly diagnosed multiple myeloma. Read More New Study Identifies Effective Treatments for Melanoma-Associated Leptomeningeal Disease Jordyn Sava December 3rd...
T Cell-Directed Therapies Are Rapidly Expanding for Myeloma September 26th 2024 Banerjee addressed factors to consider when selecting a regimen, the available treatments in this category, and their key differences. Watch Leveraging AI for More Accurate Multiple Myeloma Predictions Alexandra Gerlach, Associ...
Find all the latest on myeloma cells at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.
Researchers discover potential target to treat severe anemia in patients unresponsive to standard treatments Red blood cells are the most abundant cells in the body. It has long been known that when red blood cells break down or anemia occurs due to bleeding, the hormone erythropoietin (EPO) incr...